Este sitio Web utiliza cookies propias y de terceros con objeto de mejorar la experiencia de navegación. Si continúa navegando estará aceptando de forma expresa el uso de estas cookies. Puede obtener más información en nuestra página Uso de Cookies

Accept

IK4-CIDETEC organized a roundtable on translational research in nanomedicine in BioSpain 2016.

17/10/2016
The event took place on September 28 and revolved around the development of nanomedicine and the main challenges posed by the transfer of these innovative technologies all the way from the laboratory to the early clinical phases, related mainly to characterization processes, the transfer of technology, regulatory requirements, industry and the market.

The roundtable was conducted by Dr. Ana Benito, a researcher of the Unit Biomaterials at IK4-CIDETEC together with Covadonga Pañeda (Director of R & D Sylentis), Simon Bacconier (Transnational Access coordinator at the EU Lab for characterization in nanomedicine), Iraida Loinaz (Health BDM at IK4-CIDETEC), Eusebio Gainza (Director of R & D BioPraxis Research) and Justin Barry (MD at Midatech Pharma).

BioSpain is the largest event in the biotechnology sector in Spain and is organized by ASEBIO, the Spanish association of the biotechnology industry. The eighth edition was held from 28 to 30 September at the Bilbao Exhibition Centre (BEC) and brought together about 30 countries, including the United States as a guest.

The opening ceremony was attended by the Minister of Economic Development and Competitiveness, Arantxa Tapia, as well as the president of Asebio, Jordi Martí; the commercial attache of the US Embassy in Spain, Keith Silver; the CEO of the Institute of Foreign Trade, Francisco Javier Garzón; and the Secretary General of Health, José Javier Castrodeza.

Share